|
[1] MASON WS,GILL US,LITWIN S,et al. HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant[J]. Gastroenterology,2016,151(5):986-998. e4.
|
|
[2] ORTEGA-PRIETO AM,DORNER M. Immune evasion strategies during chronic hepatitis B and C virus infection[J]. Vaccines,2017,5(3). pii:E24.
|
|
[3] FRIEDMAN SL. Hepatic stellate cells:Protean,multifunctional,and enigmatic cells of the liver[J]. Physiol Rev,2008,88(1):125-172.
|
|
[4] KIM BM,ABDELFATTAH AM,VASAN R,et al. Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis[J]. Sci Rep,2018,8(1):7499.
|
|
[5] BONNARDEL J,T'JONCK W,GAUBLOMME D,et al. Stellate cells,hepatocytes,and endothelial cells imprint the Kupffer cell identity on monocytes colonizing the liver macrophage niche[J]. Immunity,2019,51(4):638-654. e9.
|
|
[6] TSUCHIDA T,FRIEDMAN SL. Mechanisms of hepatic stellate cell activation[J]. Nat Rev Gastroenterol Hepatol,2017,14(7):397-411.
|
|
[7] FASBENDER F,WIDERA A,HENGSTLER JG,et al. Natural killer cells and liver fibrosis[J]. Front Immunol,2016,7:19.
|
|
[8] RESHEQ YJ,LI KK,WARD ST,et al. Contact-dependent depletion of hydrogen peroxide by catalase is a novel mechanism of myeloid-derived suppressor cell induction operating in human hepatic stellate cells[J]. J Immunol,2015,194(6):2578-2586.
|
|
[9] KUBES P,MEHAL WZ. Sterile inflammation in the liver[J].Gastroenterology,2012,143(5):1158-1172.
|
|
[10] YANG Q,SHI Y,YANG Y,et al. The sterile inflammation in the exacerbation of HBV-associated liver injury[J]. Mediators Inflamm,2015,2015:508681.
|
|
[11] PELLICORO A,RAMACHANDRAN P,IREDALE JP,et al. Liver fibrosis and repair:Immune regulation of wound healing in a solid organ[J]. Nat Rev Immunol,2014,14(3):181-194.
|
|
[12] ELLIS EL,MANN DA. Clinical evidence for the regression of liver fibrosis[J]. J Hepatol,2012,56(5):1171-1180.
|
|
[13] QIAO H,ZHOU Y,QIN X,et al. NADPH oxidase signaling pathway mediates mesenchymal stem cell-induced inhibition of hepatic stellate cell activation[J]. Stem Cells Int,2018,2018:1239143.
|
|
[14] LIASKOU E,ZIMMERMANN HW,LI KK,et al. Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics[J]. Hepatology,2013,57(1):385-398.
|
|
[15] BILITY MT,CHENG L,ZHANG Z,et al. Hepatitis B virus infection and immunopathogenesis in a humanized mouse model:Induction of human-specific liver fibrosis and M2-like macrophages[J]. PLo S Pathog,2014,10(3):e1004032.
|
|
[16] SONG H,TAN G,YANG Y,et al. Hepatitis B vrus-induced imbalance of inflammatory and antiviral signaling by differential phosphorylation of STAT1 in human monocytes[J]. J Immunology,2019,202(8):2266-2275.
|
|
[17] TACKE F,ZIMMERMANN HW. Macrophage heterogeneity in liver injury and fibrosis[J]. J Hepatol,2014,60(5):1090-1096.
|
|
[18] SASAKI R,DEVHARE PB,STEELE R,et al. Hepatitis C virus-induced CCL5 secretion from macrophages activates hepatic stellate cells[J]. Hepatology,2017,66(3):746-757.
|
|
[19] LI H,ZHENG HW,CHEN H,et al. Hepatitis B virus particles preferably induce Kupffer cells to produce TGF-β1 over pro-inflammatory cytokines[J]. Dig Liver Dis,2012,44(4):328-333.
|
|
[20] ZHAI N,LI H,SONG H,et al. Hepatitis C virus induces MDSCs-like monocytes through TLR2/PI3K/AKT/STAT3 signaling[J]. PLo S One,2017,12(1):e0170516.
|
|
[21] XU Y,ZHAO W,XU J,et al. Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2[J]. Oncotarget,2016,7(8):8866-8878.
|
|
[22] HCHST B,SCHILDBERG FA,SAUERBORN P,et al. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion[J]. J Hepatol,2013,59(3):528-535.
|
|
[23] HARTWIG T,MONTINARO A,von KARSTEDT S,et al. The TRAIL-induced cancer secretome promotes a tumor-supportive immune microenvironment via CCR2[J]. Mol Cell,2017,65(4):730-742. e5.
|
|
[24] JI J,EGGERT T,BUDHU A,et al. Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma[J]. Hepatology,2015,62(2):481-495.
|
|
[25] MICHAEL A,CALIGIURI. Human natural killer cells[J]. Blood,2008,112:3.
|
|
[26] FU B,TIAN Z,WEI H. Subsets of human natural killer cells and their regulatory effects[J]. Immunology,2014,141(4):483-489.
|
|
[27] MONTALDO E,del ZOTTO G,DELLA CHIESA M,et al. Human NK cell receptors/markers:A tool to analyze NK cell development,subsets and function[J]. Cytometry A,2013,83(8):702-713.
|
|
[28] YANG Y,HAN Q,HOU Z,et al. Exosomes mediate hepatitis B virus(HBV)transmission and NK-cell dysfunction[J].Cell Mol Immunol,2017,14(5):465-475.
|
|
[29] SUN C,SUN H,ZHANG C,et al. NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma[J]. Cell Mol Immunol,2015,12(3):292-302.
|
|
[30] LI J,LIU K,LIU Y,et al. Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity[J]. Nat Immunol,2013,14(8):793-803.
|
|
[31] TOSELLO-TRAMPONT A,SURETTE FA,EWALD SE,et al.Immunoregulatory role of NK cells in tissue inflammation and regeneration[J]. Front Immunol,2017,8:301.
|
|
[32] SHIFRIN N,RAULET DH,ARDOLINO M. NK cell self tolerance,responsiveness and missing self recognition[J]. Semin Immunol,2014,26(2):138-144.
|
|
[33] LI T,YANG Y,SONG H,et al. Activated NK cells kill hepatic stellate cells via p38/PI3K signaling in a TRAIL-involved degranulation manner[J]. J Leukoc Biol,2019,105(4):695-704.
|
|
[34] TU Z,HAMALAINEN-LAANAYA HK,CRISPE IN,et al. Synergy between TLR3 and IL-18 promotes IFN-γdependent TRAIL expression in human liver NK cells[J]. Cell Immunol,2011,271(2):286-291.
|
|
[35] LI X,ZHANG M,LIU J,et al. Intrahepatic NK cells function suppressed in advanced liver fibrosis[J]. Eur J Clin Invest,2016,46(10):864-872.
|
|
[36] CASTRICONI R,CANTONI C,DELLA CHIESA M,et al. Transforming growth factorβ1 inhibits expression of NKp30 and NKG2D receptors:Consequences for the NK-mediated kil ing of dendritic cells[J]. Proc Natt Acad Sci U S A,2003,100(7):4120-4125.
|
|
[37] JEONG WI,PARK O,SUH YG,et al. Suppression of innate immunity(natural killer cell/interferon-γ)in the advanced stages of liver fibrosis in mice[J]. Hepatology,2011,53(4):1342-1351.
|
|
[38] SHI J,ZHAO J,ZHANG X,et al. Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients[J]. Sci Rep,2017,7:44544.
|
DownLoad: